Aller au contenu principal
2023 conference-abstract

PATIENT'S PERSPECTIVES ON TREATMENT ADHERENCE IN HYPERTENSION: RESULTS OF AN ESH SURVEY IN POLAND

0Citations signalées, ce qui n’est pas une note de qualité
9Institutions déclarées
8Pays d’affiliation déclarés

Rattachement africain : pl, fr, be, pt, gb, cz, nl, de. Niveau de preuve : code pays fourni par la source.

Le résumé fourni par la source

Objective: The ESH Working group on Lifestyle, Cardiovascular Therapy and Adherence has developed a web-based questionnaire in different languages to investigate patients’ perspectives on hypertension and treatment adherence. The objective of this survey was to decipher patients’ perception of motivations for and barriers to treatment adherence in hypertension. Design and method: In Poland, a dedicated recruitment strategy has been developed to invite adult patients to complete the survey via targeted information on patient group websites and social media only. In other countries a direct communication from healthcare professional to patient was preferred. Data were collected from May to September 2022. Descriptive statistics were used for analyses. Results: We included 1359 participants (962 men (71%); 67% were hypertensive for >5 years, 88% were treated with antihypertensive medications for at least 3 months). The total median number of tablets taken every day was 4 of which 2 were antihypertensive medications. Antihypertensive medications were prescribed most frequently once (56%) or twice (36%) daily. On a 10-point Likert scale, participants reported a modest impact of hypertension on their quality of life (4), social and family life (2). The median level of stress was 5 out of 10 points. Ninety two of patients performed self-blood pressure measurements at home, most frequently every day (34%) and a few times a week (28%). Self-reported adherence to treatment was perfect in 43% of patients, very high in 30% and intermediate-low in 26% of patients. Main reasons for low adherence to medication included forgetfulness (41%), improvement in well-being (15%), side effects (14%) and running out of medications (11%). The most useful approaches to support adherence reported by participants were cheaper and single-pill combinations as well as leaflets providing better information on treatment. Information provided by physicians on hypertension and its treatment was considered sufficient only for 54% of patients. Conclusions: In a web-based ESH survey in Poland, over 1,300 participants reported a modest impact of hypertension on their quality of life and a moderate level of anxiety, usually non-intentional non-adherence to prescribed antihypertensive medications, and the necessity to improve the information provided to them.

Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.

Le contrôle bibliographique ouvert

DOI retrouvé dans Crossref DOI retrouvé ; titre concordant.

Titre Crossref
PATIENT'S PERSPECTIVES ON TREATMENT ADHERENCE IN HYPERTENSION: RESULTS OF AN ESH SURVEY IN POLAND
Date Crossref
01/06/2023
Éditeur
Ovid Technologies (Wolters Kluwer Health)
Type
journal-article

Ce recoupement confirme des métadonnées liées au DOI. Il ne confirme ni la méthode ni les conclusions de l’étude, et il ne compte pas comme une seconde source scientifique indépendante.

Les institutions déclarées

Une affiliation ne permet pas de déduire la nationalité d’un auteur.

Les sujets associés

Medication Adherence and Compliance

BNTIC News n’est pas le producteur de ces données. Les publications sont interrogées à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, AfricArXiv, ROR et la Banque mondiale, sans clé d’accès. OpenAlex reste optionnel. Aucun service payant n’est nécessaire et aucune donnée externe n’est enregistrée en base. Consulter les sources et leurs limites.